Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
Active, not recruiting · NCT04522544 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-06-23 | NCT04522544 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Hannover Medical School | 52 |
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 34 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Klinikum rechts der Isar der Technischen Universität München | München | Germany | 8 |
| Medizinische Hochschule Hannover | Hanover | Germany | 90 |
| München Klinik Bogenhausen | München | Germany | 1 |
| Universitätsklinikum Bonn | Bonn | Germany | 29 |
| Universitätsklinikum Essen | Essen | Germany | 39 |
| Universitätsklinikum Jena | Jena | Germany | 31 |
| Universitätsklinikum Köln | Cologne | Germany | 15 |
| Universitätsklinikum Münster | Münster | Germany | 35 |
| Universitätsklinikum Tübingen | Tübingen | Germany | 57 |
| Universitätsmedizin Göttingen | Göttingen | Germany | 18 |
| Universtitätsklinikum Schleswig-Holstein | Lübeck | Germany | 1 |